0000000001008642

AUTHOR

Klaus R. Liedl

0000-0002-0985-2299

showing 1 related works from this author

Discovery of Retinoic Acid-Related Orphan Receptor γt Inverse Agonists via Docking and Negative Image-Based Screening

2018

Retinoic acid-related orphan receptor γt (RORγt) has a vital role in the differentiation of T-helper 17 (TH17) cells. Potent and specific RORγt inverse agonists are sought for treating TH17-related diseases such as psoriasis, rheumatoid arthritis, and type 1 diabetes. Here, the aim was to discover novel RORγt ligands using both standard molecular docking and negative image-based screening. Interestingly, both of these in silico techniques put forward mostly the same compounds for experimental testing. In total, 11 of the 34 molecules purchased for testing were verified as RORγt inverse agonists, thus making the effective hit rate 32%. The pIC50 values for the compounds varied from 4.9 (11 μ…

lymphocytes0301 basic medicinedrug designGeneral Chemical EngineeringIn silicoRetinoic acidStructural diversityComputational biologyta3111Scaffold hopping01 natural sciencesArticlelääkesuunnittelulcsh:Chemistry03 medical and health scienceschemistry.chemical_compoundRAR-related orphan receptor gammaInverse agonistOrphan receptorligandsChemistryta1182liganditGeneral Chemistryproteins0104 chemical sciences010404 medicinal & biomolecular chemistry030104 developmental biologylcsh:QD1-999Docking (molecular)proteiinitlymfosyytitACS Omega
researchProduct